ArticleBiomedical optics express2019

Diffuse optical tomography of the breast: a potential modifiable biomarker of breast cancer risk with neoadjuvant chemotherapy.

Mirella L Altoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.